CeriBell, Inc. Capital Expenditures
CeriBell, Inc. (CBLL) reported Capital Expenditures of $142.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-10
- CeriBell, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $17.00K, a 76.06% decline year-over-year.
- CeriBell, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $125.00K, a 15.54% decline year-over-year.
- CeriBell, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $179.00K, a 49.86% decline year-over-year.
- CeriBell, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $369.00K, a 34.92% decline year-over-year.
- CeriBell, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $767.00K, a 42.76% decline from fiscal 2024.
- CeriBell, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $1.34M, a 36.32% increase from fiscal 2023.
- CeriBell, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $983.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $142.00K 10-Q · filed 2026-08-10 | $321.00K derived: sum of 3 quarters · filed 2026-08-10 | $690.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $125.00K 10-Q · filed 2026-05-11 | $304.00K derived: sum of 2 quarters · filed 2026-05-11 | $673.00K derived: sum of 3 quarters · filed 2026-05-11 | $744.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $548.00K derived: sum of 2 quarters · filed 2026-02-24 | $619.00K derived: sum of 3 quarters · filed 2026-08-10 | $767.00K 10-K · filed 2026-02-24 |
| 2025-09-30 | $369.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $440.00K derived: sum of 2 quarters · filed 2026-08-10 | $588.00K 10-Q · filed 2025-11-04 | $945.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $71.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $219.00K 10-Q · filed 2026-08-10 | $576.00K derived: sum of 3 quarters · filed 2026-08-10 | $1.14M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $148.00K 10-Q · filed 2026-05-11 | $505.00K derived: sum of 2 quarters · filed 2026-05-11 | $1.07M derived: sum of 3 quarters · filed 2026-05-11 | $1.39M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $357.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $924.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.25M derived: sum of 3 quarters · filed 2026-02-24 | $1.34M 10-K · filed 2026-02-24 |
| 2024-09-30 | $567.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $888.00K derived: sum of 2 quarters · filed 2025-11-04 | $983.00K 10-Q · filed 2025-11-04 | $1.46M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $321.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $416.00K 10-Q · filed 2025-08-05 | $893.00K derived: sum of 3 quarters · filed 2025-08-05 | |
| 2024-03-31 | $95.00K 10-Q · filed 2025-05-08 | $572.00K derived: sum of 2 quarters · filed 2025-05-08 | ||
| 2023-12-31 | $477.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $983.00K 10-K · filed 2025-02-25 | ||
| 2023-09-30 | $506.00K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |